Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
21.08. | Chordate Medical Holding AB: Chordate Announces Cost Reduction and Focus on Company Sale | 81 | GlobeNewswire (Europe) | Chordate Medical Holding AB (Publ.) (the "Company") has adopted a cost reduction program that includes focusing activities on the continued ambition to sell the Company. Together with the recently completed... ► Artikel lesen | |
19.08. | Chordate Medical Holding AB: Chordate reports preliminary conclusions from long-term study on chronic migraine: PM010 | 114 | GlobeNewswire (Europe) | Since this Post Market Surveillance study is open-label (uncontrolled), it is possible - and the sponsor's responsibility - to actively monitor study data during the ongoing trial. It is both scientifically... ► Artikel lesen | |
17.07. | Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 211 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Chordate Medical Holding AB (publ), held on 17 July 2025, the following resolution was passed. All resolutions were adopted in accordance with the proposals previously... ► Artikel lesen | |
23.05. | Chordate Medical Holding AB: Chordate Medical Holding AB (publ) Interim Report January-March 2025 | 150 | GlobeNewswire (Europe) | Summary of the period January-March 2025Net turnover was SEK 596,105 (257,677)Cash flow from operating activities was SEK -6,046,406 (-5,908,058)Profit/loss after financial items was SEK -5,756,609... ► Artikel lesen | |
15.04. | CHORDATE MEDICAL HOLDING: Chordate Medical obtains trademark registration for Ozilia in the US | 2 | Cision News | ||
CHORDATE MEDICAL Aktie jetzt für 0€ handeln | |||||
28.03. | Chordate Medical Holding AB: Year-End Report Chordate Medical Holding AB (publ) January - December 2024 | 197 | GlobeNewswire (Europe) | Summary of the period October-December 2024Net turnover was SEK 86,076 (481,597)Cash flow from operating activities was SEK -4,659,856 (-7,501,648)Profit/loss after financial items was SEK -8,529,829... ► Artikel lesen | |
31.01. | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Chordate Medical Holding AB (publ) | 268 | GlobeNewswire | With effect from February 03, 2025, the unit rights in Chordate Medical Holding AB (publ) will be traded on First North Growth Market. Trading will continue up until and including February 12, 2025.
Instrument:
Unit... ► Artikel lesen | |
29.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 29.01.2025 | 663 | Xetra Newsboard | Das Instrument B7Z0 NO0012861667 ARRIBATEC GROUP NK 0,10 EQUITY wird ex Kapitalmassnahme gehandelt am 29.01.2025 The instrument B7Z0 NO0012861667 ARRIBATEC GROUP NK 0,10 EQUITY is traded ex capital... ► Artikel lesen | |
28.01. | Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 168 | GlobeNewswire (Europe) | The following resolutions was adopted at the extraordinary general meeting of Chordate Medical Holding AB (publ) held on 28 January 2025
Amendment of the articles of associationThe general meeting resolved... ► Artikel lesen | |
05.11.24 | Chordate Medical Holding AB: Chordate Medical Holding (publ) Interim Report January-September 2024 | 192 | GlobeNewswire (Europe) | Summary of the period July-September 2024Net turnover was SEK 147,993 (210,947)Cash flow from operating activities was SEK -5,126,552 (-4,325,051)Profit/loss after financial items was SEK -5,681,292... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 47,640 | +1,56 % | Siemens Healthineers AG: Q4 2025 und GJ 2026 voraussichtlich von Gegenwind belastet. KAUFEN. | Die Siemens Healthineers AG (SHL) hat ihr Geschäftsjahr 2025 gestern beendet. Rückblickend lieferte SHL ein solides 9M FY25 (+6,4 % yoy, berichtete EBIT-Marge 13,3 %) und erhöhte die Prognose auf 5... ► Artikel lesen | |
FRESENIUS | 47,160 | +0,32 % | ROUNDUP/Aktien Frankfurt Schluss: Dax setzt wieder zurück - Richtungssuche | FRANKFURT (dpa-AFX) - Nach den leichten Gewinnen am Vortag hat der Dax am Donnerstag wieder den Rückwärtsgang eingelegt. Als Belastung für die hiesigen Börsen erwiesen sich zeitweise vor allem die... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 28,360 | -1,36 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
GERRESHEIMER | 37,960 | +3,72 % | Aktien KW 39 Mut fehlt, aber verpassen will man auch nichts. September abhaken und dann? News. Mutares. Nordex. SFC Energy. Artec. Circus. Heidelberg Pharma. Rheinmetall. Gerresheimer | Aktien:mBei rund 23.300 Punkten setzen spätestens Käufe ein, bei rund 23.800 Punkten werden die Anleger vorsichtig. So stellt sich der DAX im september dar - bisher. Und in den USA feiern die Märkte... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,570 | +0,18 % | Fresenius Medical: Erste Hoffnungsschimmer im Chart | Die Fresenius-Medical-Aktie zeigt erste Anzeichen einer möglichen Bodenbildung. Kann der Widerstand bei 44,36 EUR überwunden werden Den vollständigen Artikel lesen ... ► Artikel lesen | |
CARL ZEISS MEDITEC | 45,240 | +3,24 % | Carl Zeiss Meditec, Gerresheimer, Hensoldt, Lufthansa, Puma, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
UNITEDHEALTH | 306,10 | -0,15 % | 3 Charts in 3x33 Sekunden - Heute mit NVIDIA, UnitedHealth Group und Palladium | Willkommen zu '3 Charts in 33 Sekunden'! Jörg Scherer stellt uns drei Charts vor, die er aktuell ganz besonders unter die Lupe nimmt. Welche Ziele oder Signale jetzt wichtig sind, erfahren Sie im Video!... ► Artikel lesen | |
GENEDX | 118,32 | +0,81 % | GeneDx announces first genomic newborn screening initiative | ||
ELEVANCE HEALTH | 298,40 | -0,33 % | Leichte Zugewinne bei der Elevance Health-Aktie (275,8959 €) | Im US-amerikanischen Wertpapierhandel liegt das Wertpapier von Elevance Health aktuell im Plus. Zuletzt zahlten Investoren für die Aktie 323,91 US-Dollar. Freuen können sich gegenwärtig die Aktionäre... ► Artikel lesen | |
NUTEX HEALTH | 107,88 | +0,82 % | Nutex Health, Inc.: Nutex Health Announces The Appointment Of Wesley Bamburg As Its New Chief Operating Officer | HOUSTON, Sept. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system... ► Artikel lesen | |
HIMS & HERS HEALTH | 46,170 | -0,04 % | Why Hims & Hers Stock Slipped Today | ||
ALIGNMENT HEALTHCARE | 16,620 | +3,58 % | Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors | ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68... ► Artikel lesen | |
KESTRA MEDICAL TECHNOLOGIES | 24,820 | +1,93 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for... ► Artikel lesen | |
KINDLY MD | 1,130 | +2,73 % | KindlyMD, Inc: KindlyMD Secures $200 Million Credit Facility from Two Prime and Completes Convertible Note Redemption | Provides Flexibility to Pursue Long-Term Growth Strategy While Preserving Bitcoin Holdings and Strengthening the Company's Balance Sheet SALT LAKE CITY, UT / ACCESS Newswire / October 3, 2025 / KindlyMD... ► Artikel lesen | |
CLEARPOINT NEURO | 27,390 | +9,34 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System | New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene Therapy SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen |